Miyuki Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Highway 191 & Hospital Drive, Chinle, AZ 86503 Phone: 928-674-7001 |
Dr. Manuel Luis Iravedra, D.M.D., B.S.PH Pharmacist Medicare: Medicare Enrolled Practice Location: Po Box Ph, Chinle, AZ 86503 Phone: 928-674-7001 |
Jillyan Harlan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ihs Chinle Hospital, Chinle, AZ 86503 Phone: 928-674-7001 |
Dr. Katherine S Post, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: U.s. 191 & Hospital Drive, Chinle, AZ 86503 Phone: 928-674-7001 |
Chau Thanh Minh Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Highway 191 And Hospital Drive, Chinle, AZ 86503 Phone: 928-674-7526 |
Dr. Andrew Coogan, PHARM,D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Po Box Ph, Chinle, AZ 86503 Phone: 928-674-7001 |
News Archive
While unconscious during deep sleep, millions of neurons' activity travels across the cerebral cortex. This phenomenon, known as slow waves, is related to the consolidation of memory.
Though the focus on typhoid fever traditionally has focused on Asia, where the disease is endemic, "[s]ince early November 2011, there has been a surge of typhoid fever outbreaks in central and southern Africa, affecting children and adults alike," Christopher Nelson, director of the Coalition against Typhoid (CaT) at the Sabin Vaccine Institute, and Ciro de Quadros, executive vice president of the Sabin Vaccine Institute, write in this Atlantic opinion piece.
NaviNet, America's largest real-time health care communications network, and New Jersey's largest health insurer, Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ), announced today an agreement in which Horizon BCBSNJ will use NaviNet's multi-payer, Web-based portal as its exclusive secure information exchange with providers.
A study led by sports medicine researcher Anne Hoch, D.O. at The Medical College of Wisconsin in Milwaukee has found that oral folic acid may provide a safe and inexpensive treatment to improve vascular function in young female runners who are amenorrheic (not menstruating).
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
› Verified 1 days ago